A general enabeling technology for manufacturing pure nanoparticles
| Organization: | Pharmaceutics International Inc., MD, US | | I.P. Brief: | A novel enabling technique to manufacture nanospheres made entirely from a single material such as carrier-free drug nanoparticles. For example, nanoparticles with 10-200 nanometers diameter can be prepared to improve solubility and dissolution. Surface-modified particles with specific receptor agonists enhances site specific targeting to tissues and cells | | Keywords: | enabling technology, nanomedicine, manufacturing of nanoparticles, nanomaterials, drug targeting, cancer treatment, hormonal therapy, enhanced absorption | | Primary Industry: | Pharma & Biotech | | Specific Market: | Advanced therapy for cancer, hormonal disorders, rhematoid arthritis, pain |
Full IP Descriptions available on-site.
| 
|
|
